Bottom line
What is HRLSX's expense ratio?
HRLSX's expense ratio is 1.2%, or about $120 a year on every $10,000 invested. That is more expensive than 74% of large blend funds we track (median 0.83%). It has no front-end sales load. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Feb 26, 2026
HRLSX fee table
| Net expense ratio | 1.2% |
|---|---|
| Gross expense ratio | 1.71% |
| Management fee | 0.8% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.66% |
| Fee waiver / reimbursement | -0.51% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 26, 2026
What HRLSX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| HRLSX | $122 | $489 | $880 | $1,977 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.2% expense ratio costs roughly $65,300 in lost growth, versus about $46,700 for the median large blend fund (0.83%).